Explore Our Innovations

Westmead Research Hub has one of the largest concentrations of biomedical, scientific and healthcare focused minds in Australia and offers industry access to an active pipeline of groundbreaking medical innovations for licensing and partnership opportunities.

Click here to view the current innovations and opportunites in "Therapeutic or Delivery", "Medical Devices" and "Diagnostics"

Westmead is home to over 1,100 full-time equivalent (FTE) research staff, across four major institutes and numerous research centres, groups and networks. The majority of these (700) are full-time researchers, including 170 leading clinician-scientists, with the remainder being research support staff.
In 2015 Westmead researchers were awarded over $79 million in Category 1 public medical research grants, and researchers at Westmead achieved a grant writing success rate of 22%, compared to a publicised national success rate of 14%.

Selected Unique Capabilities

• Sydney Centre for Cell and Gene Therapy, a GMP compliant facility supporting Pancreas Islet Transplantation, T cell adoptive immunotherapy and Gene Therapy
• ProCanTM Industrial scale proteomics for diagnostic development and target discovery
• Cell Bank Australia, Cell bank repository, including an exclusive partnership with ECACC, and cell line testing services
• EPIC Lab: 3D Design and printing of novel orthopaedic implants for children with bone malformations or fractures.
• Vector and Genome Engineering Facility, state of the art technology to create vectors for the delivery of gene therapies into diseased tissue, and development of this technology.


Western Sydney Local Health District (WSLHD)
& Sydney Children's Hospital Network (SCHN)
David Markwell
IP and Commercialisation Manager
P: +61 439 875 825
University of Sydney (USYD)
& Westmead Institute for Medical Research (WIMR)
Dr Nadia Pece-Barbara
Commercial Theme Leader, Westmead Precinct
P: +61 417 168 561
Children’s Medical Research Institute (CMRI)
Dr Julia Hill
Head of Commercialisation
P: +61 2 8865 2839